December 31, 2022
6 min watch
Save
VIDEO: Surgeon shares pearls on treating glaucoma with SLT, intracameral medications
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
NEW YORK — In a presentation at OSN New York, Nathan Radcliffe, MD, discusses the benefits of performing selective laser trabeculoplasty on patients with open-angle glaucoma.
Radcliffe also provides insight on which patients may benefit from intracameral glaucoma medications.
Published by:
Sources/Disclosures
Collapse
Source:
Radcliffe N. When and how I use SLT and intracameral glaucoma medications. Presented at: OSN New York and OSN New York Retina; Nov. 11-Nov. 13, 2022; New York.
Disclosures:
Radcliffe reports having financial disclosures for Aerie, Alcon, Aldeyra, Alimera, Allergan/AbbVie, Avellino, Bausch + Lomb, Beaver-Visitec International, Belkin, Carl Zeiss Meditec, CATS, Dompe, Ellex, Elios Vision, Equinox, EyePoint, Glaukos, Imprimis, Iridex, IrisVision, Kala, Lumenis, New World Medical, Novartis, Ocular Science, Ocular Therapeutix, Omeros, Rayner, Reichert, Santen, Sight Sciences, SpyGlass, Tarsus, TearClear, Thea and ViaLase.
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.